Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: ECT026
MIFTS: 51

Ectopic Pregnancy

Categories: Rare diseases, Reproductive diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Ectopic Pregnancy

About this section

MalaCards integrated aliases for Ectopic Pregnancy:

Name: Ectopic Pregnancy 12 76 53 43 15 73
Pregnancy, Ectopic 44
Pregnancy Ectopic 55
Eccyesis 12

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Reproductive diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:0060329
ICD10 33 O00 O00.9
ICD9CM 35 633 633.9
MeSH 44 D011271
NCIt 50 C34945
UMLS 73 C0032987
Sources

Summaries for Ectopic Pregnancy

About this section
MedlinePlus : 43 The uterus, or womb, is the place where a baby grows when a woman is pregnant. If you have an ectopic pregnancy, the fertilized egg grows in the wrong place, outside the uterus, usually in the fallopian tubes. The result is usually a miscarriage. Ectopic pregnancy can be a medical emergency if it ruptures. Signs of ectopic pregnancy include Abdominal pain Shoulder pain Vaginal bleeding Feeling dizzy or faint Get medical care right away if you have these signs. Doctors use drugs or surgery to remove the ectopic tissue so it doesn't damage your organs. Many women who have had ectopic pregnancies go on to have healthy pregnancies later. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary : Ectopic Pregnancy, also known as pregnancy, ectopic, is related to hydatidiform mole, recurrent, 1 and placental site trophoblastic tumor, and has symptoms including pelvic pain and morning sickness. An important gene associated with Ectopic Pregnancy is CGA (Glycoprotein Hormones, Alpha Polypeptide), and among its related pathways/superpathways are Peptide hormone metabolism and Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors. The drugs Methotrexate and Mifepristone have been mentioned in the context of this disorder. Affiliated tissues include uterus, heart and endothelial, and related phenotype is cardiovascular system.

Disease Ontology : 12 A female reproductive system disease characterized by the implantation of the embryo outside the uterine cavity.

Wikipedia : 76 Ectopic pregnancy is a complication of pregnancy in which the embryo attaches outside the uterus. Signs... more...

Sources

Related Diseases for Ectopic Pregnancy

About this section

Diseases related to Ectopic Pregnancy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 118)
# Related Disease Score Top Affiliating Genes
1 hydatidiform mole, recurrent, 1 32.7 CGA CGB3 CGB5
2 placental site trophoblastic tumor 30.5 CGB3 CGB5
3 choriocarcinoma 30.5 CGA CGB3 CGB5 CGB7
4 placenta disease 30.1 CGB3 PAPPA PGF
5 pelvic inflammatory disease 11.4
6 chlamydia 11.3
7 gestational trophoblastic tumor 11.2
8 hydatidiform mole, recurrent, 2 10.9
9 diethylstilbestrol syndrome 10.9
10 mixed germ cell tumor 10.8 CGA CGB3
11 sacrococcygeal teratoma 10.8 CGA CGB7
12 nonseminomatous germ cell tumor 10.8 CGB5 CGB7
13 testicular seminoma 10.8 CGA CGB3
14 anorchia 10.8 CGA CGB5
15 trisomy 22 10.6 CGB7 PAPPA
16 hydrocele 10.6 CGA VEGFA
17 testicular cancer 10.5 CGA CGB3 CGB5
18 neovascular glaucoma 10.5 PGF VEGFA
19 placenta accreta 10.5 CGB3 PGF
20 epithelioid hemangioendothelioma 10.5 PGF VEGFA
21 kuhnt-junius degeneration 10.5 PGF VEGFA
22 cancer-associated retinopathy 10.4 PGF VEGFA
23 ulcerative stomatitis 10.4 CGB3 CGB7
24 triploidy 10.4 CGA CGB7 PAPPA
25 retinal vascular occlusion 10.4 PGF VEGFA
26 seminoma 10.3 CGA CGB3 CGB5 CGB7
27 testicular disease 10.3 CGA PROKR1
28 orofaciodigital syndrome viii 10.3 ADAM12 CGA PAPPA
29 cervicitis 10.2
30 salpingitis 10.1
31 mixed ductal-endocrine carcinoma 10.0 CGB3 CGB7
32 infertility 10.0
33 endotheliitis 10.0
34 down syndrome 10.0 CGB3 CGB7 PAPPA
35 gestational choriocarcinoma 9.9
36 endometriosis 9.9
37 ovarian cyst 9.9
38 placental insufficiency 9.9 PGF PROK1 VEGFA
39 ovarian hyperstimulation syndrome 9.8
40 leukemia 9.8
41 cryptorchidism, unilateral or bilateral 9.8 CGA CGB5 PROKR2
42 vaginitis 9.8
43 cystic teratoma 9.8
44 teratoma 9.8
45 gestational trophoblastic neoplasm 9.8
46 appendicitis 9.8
47 hepatitis 9.7
48 tuberculous salpingitis 9.7
49 myoma 9.7
50 trophoblastic neoplasm 9.7

Graphical network of the top 20 diseases related to Ectopic Pregnancy:



Diseases related to Ectopic Pregnancy
Sources

Symptoms & Phenotypes for Ectopic Pregnancy

About this section

UMLS symptoms related to Ectopic Pregnancy:


pelvic pain, morning sickness

MGI Mouse Phenotypes related to Ectopic Pregnancy:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.23 MYH11 PAPPA PGF PIK3C2A PROKR1 VEGFA
Sources

Drugs & Therapeutics for Ectopic Pregnancy

About this section

Drugs for Ectopic Pregnancy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 155)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methotrexate Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1959-05-2, 59-05-2 126941
2
Mifepristone Approved, Investigational Phase 4,Not Applicable 84371-65-3 55245
3
Misoprostol Approved Phase 4,Not Applicable 59122-46-2 5282381
4
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757
5 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 979-32-8
6
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2 28014-46-2
7
Buserelin Approved, Investigational Phase 4 57982-77-1
8
Trimethobenzamide Approved, Investigational Phase 4 138-56-7 5577
9
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
10
Tamoxifen Approved Phase 4 10540-29-1 2733526
11
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
12
Norgestrel Approved Phase 4 6533-00-2 13109
13
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 59-30-3 6037
14
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 58-05-9 143 6006
15 Antimetabolites Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
16 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
17 Antirheumatic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
18 Dermatologic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
19 Folic Acid Antagonists Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
20 Immunosuppressive Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
21 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
22 Vitamin B Complex Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
23 Antacids Phase 4,Phase 3
24 Anti-Ulcer Agents Phase 4,Phase 3
25 Contraceptive Agents Phase 4,Phase 3,Phase 2,Not Applicable
26 Contraceptives, Oral Phase 4,Phase 2
27 Contraceptives, Postcoital Phase 4
28 Gastrointestinal Agents Phase 4,Phase 3
29 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
32 Luteolytic Agents Phase 4,Phase 3,Phase 2,Not Applicable
33 Oxytocics Phase 4,Phase 1
34 Chorionic Gonadotropin Phase 4,Phase 3,Phase 2,Not Applicable
35 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Not Applicable
36 Triptorelin Pamoate Phase 4,Phase 2,Phase 3,Not Applicable
37 Progestins Phase 4,Phase 3,Phase 2
38 Bone Density Conservation Agents Phase 4
39 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2
40 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2
41 Estrogen Antagonists Phase 4,Phase 2,Not Applicable
42 Estrogens Phase 4,Phase 2,Phase 3,Not Applicable
43 Contraceptives, Oral, Combined Phase 4,Phase 2
44 Follicle Stimulating Hormone Phase 4,Phase 3,Phase 1,Phase 2
45 Fertility Agents Phase 4,Phase 3,Phase 2,Not Applicable
46 Vaccines Phase 4,Phase 3,Phase 1
47 Estrogen Receptor Modulators Phase 4,Phase 2
48 Selective Estrogen Receptor Modulators Phase 4,Phase 2
49 Ethinyl estradiol, levonorgestrel drug combination Phase 4
50 Ethinyl Estradiol-Norgestrel Combination Phase 4

Interventional clinical trials:

(show top 50) (show all 138)
# Name Status NCT ID Phase Drugs
1 Laparascopy Versus Laparatomy in the Management of Ruptured Ectopic Pregnancy Unknown status NCT01932957 Phase 4
2 BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success Unknown status NCT01860690 Phase 4 Methotrexate
3 Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility Unknown status NCT00137982 Phase 4
4 Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Unknown status NCT02745093 Phase 4 Mifepristone;Misoprostol
5 Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy Completed NCT01876004 Phase 4 Methotrexate;Placebo
6 Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy Completed NCT01662167 Phase 4 Single;Multipe
7 Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients Completed NCT02466204 Phase 4 corifollitropin alfa;Follitropin Beta
8 Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin Completed NCT00461916 Phase 4 Half-Dose Depot Triptorelin;Reduced-Dose Daily Buserelin
9 Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction Completed NCT01081626 Phase 4 Recombinant FSH (follitropin alpha)
10 Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents Completed NCT00534638 Phase 4
11 TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment Recruiting NCT03164551 Phase 4
12 Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection Not yet recruiting NCT03532464 Phase 4 azithromycin;doxycycline
13 The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle. Not yet recruiting NCT03060304 Phase 4 Tamoxifen;estradiol valerate
14 Pituitary Down-regulation Before IVF for Women With Endometriosis Terminated NCT01757249 Phase 4 Combined Oral Contraceptive Pill (Microgynon 30)
15 Low-dose Gonal-f® in Ovulation Induction Terminated NCT01871532 Phase 4 Gonal-f®
16 Two-Dose Methotrexate for Ectopic Pregnancy Completed NCT00194272 Phase 3 Methotrexate
17 Methotrexate Treatment for Ectopic Pregnancy Completed NCT01855568 Phase 3
18 A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization Completed NCT00615251 Phase 3 DR-2011;Crinone 8%
19 Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel Completed NCT01863680 Phase 3 COL-1620;Gonadotropin-releasing hormone (GnRH) analogue;Follicle-stimulating hormone (FSH);Human Chorionic Gonadotropin (hCG)
20 Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714) Completed NCT00696878 Phase 3 Corifollitropin alfa;Progesterone
21 A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism Completed NCT01084265 Phase 3 Recombinant human luteinizing hormone (r-hLH);Recombinant human follicle-stimulating hormone (r-hFSH);Human chorionic gonadotropin (hCG)
22 Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study Completed NCT01190189 Phase 3
23 Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles Completed NCT01798862 Phase 2, Phase 3
24 Impact of Local Biopsy to the Endometrium Prior to Controlled Ovarian Stimulation on Clinical Pregnancy Completed NCT01064193 Phase 3
25 Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects Completed NCT00779766 Phase 3
26 GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT Completed NCT03039049 Phase 3 Triptorelin 0.1 mg
27 A Study to Assess if Scratching the Lining of the Womb Prior to IVF Treatment Increases the Chances of Pregnancy Completed NCT01882842 Phase 2, Phase 3
28 Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls Completed NCT01381575 Phase 3
29 Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age. Completed NCT00481767 Phase 3 Placebo Al(OH)3
30 Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Completed NCT00122681 Phase 3
31 Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study Completed NCT00929526 Phase 3
32 Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) Completed NCT01185704 Phase 3 Cetrorelix acetate;Cetrorelix acetate;Recombinant Human Choriogonadotropin (r-hCG);Recombinant human follicle stimulating hormone (r-hFSH)
33 Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older Completed NCT00294047 Phase 3
34 PERgoveriS In Stratified Treatment for Assisted Reproductive Technique Completed NCT01297465 Phase 3 Gonal-f®;Pergoveris®;Pergoveris®;Recombinant human chorionic gonadotropin (r-hCG)
35 Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location Recruiting NCT02152696 Phase 3 Methotrexate
36 Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss Recruiting NCT03305263 Phase 3 Hydroxychloroquine;Hydroxychloroquine placebo
37 Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women Recruiting NCT03296527 Phase 3 Follitropin alfa;FE 999049
38 Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01823315 Phase 3 MTX 1;MTX 2
39 G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score Not yet recruiting NCT03163862 Phase 2, Phase 3 G-CSF administration;Saline Solution
40 Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF Terminated NCT01798836 Phase 2, Phase 3
41 Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle Terminated NCT01071200 Phase 3 Recombinant human Follicle Stimulating Hormone (r-hFSH) and Recombinant human Luteinizing Hormone (r-hLH);r-hFSH
42 Endometrial Injury for Assisted Reproduction Terminated NCT01132144 Phase 3
43 Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles Unknown status NCT02677259 Phase 2 17-beta estradiol;Micronized progesterone
44 Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF Unknown status NCT02173977 Phase 2
45 The Effect of Sildenafil Citrate on the Success Rate of Ovulation Induction Using Clomiphene Completed NCT02663830 Phase 2 Sildenafil & clomiphene citrate;clomiphene only
46 Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation Completed NCT01319695 Phase 1, Phase 2 corifollitropin alfa;recombinant follicle stimulating hormone (FSH)
47 Nifedipine Treatment on Uterine Contractility in IVF Recruiting NCT02072291 Phase 2 Nifedipine
48 A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. Recruiting NCT03564509 Phase 2 FE 999302 (dose 1) and follitropin delta;FE 999302 (dose 2) and follitropin delta;FE 999302 (dose 3) and follitropin delta;FE 999302 (dose 4) and follitropin delta;FE 999302 (dose 5) and follitropin delta
49 RCT for Women With a Persisting Pregnancy of Unknown Location Terminated NCT01800162 Phase 1, Phase 2 Methotrexate
50 A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693) Terminated NCT00697255 Phase 2 corifollitropin alfa

Search NIH Clinical Center for Ectopic Pregnancy

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: pregnancy, ectopic

Sources

Genetic Tests for Ectopic Pregnancy

About this section
Sources

Anatomical Context for Ectopic Pregnancy

About this section

MalaCards organs/tissues related to Ectopic Pregnancy:

41
Uterus, Heart, Endothelial, Testes, Ovary, Liver, Pituitary
Sources

Publications for Ectopic Pregnancy

About this section

Articles related to Ectopic Pregnancy:

(show top 50) (show all 916)
# Title Authors Year
1
Irish women's experience of Ectopic pregnancy. ( 29804760 )
2018
2
Ectopic pregnancy: Review of 80 cases. ( 29692487 )
2018
3
Non-surgical management of caesarean scar ectopic pregnancy - a five-year experience. ( 29884080 )
2018
4
Liver ectopic pregnancy complicating a focal nodular hyperplasia. ( 29731143 )
2018
5
To evaluate the feasibility of magnetic resonance imaging in predicting unusual site ectopic pregnancy: a retrospective cohort study. ( 29349699 )
2018
6
MicroRNAs as Potential Serum Biomarkers for Early Detection of Ectopic Pregnancy. ( 29796356 )
2018
7
Diagnosis and surgical therapy of the retroperitoneal ectopic pregnancy: A case report. ( 29933172 )
2018
8
Comparison of Four Methods of Treating Ectopic Pregnancy: A Retrospective Cohort Study. ( 29375148 )
2018
9
Acute intestinal obstruction due to extrinsic compression by previa myoma and ectopic pregnancy: a case report. ( 29335010 )
2018
10
Micro-CT in an ectopic pregnancy: New radiological and microscopical perspectives (and level) in the study of the Fallopian tube. ( 29279158 )
2018
11
Diagnostic utility of CT in differentiating between ruptured ovarian corpus luteal cyst and ruptured ectopic pregnancy with hemorrhage. ( 29316947 )
2018
12
Coexistence of a Tubal Ectopic Pregnancy and Tubal Leiomyoma. ( 29704678 )
2018
13
Uterine artery embolization combined with local infusion of methotrexate and 5- fluorouracil in treating ectopic pregnancy: A CONSORT-compliant article. ( 29384854 )
2018
14
A cohort of women with ectopic pregnancy: challenges in diagnosis and management in a rural hospital in a low-income country. ( 29751791 )
2018
15
Successful Management of Cervical Ectopic Pregnancy with Bilateral Uterine Artery Embolization and Methotrexate. ( 29854485 )
2018
16
Appendiceal Endometriosis and Ectopic Pregnancy Occurring Simultaneously. ( 29420399 )
2018
17
A rare case of ectopic pregnancy at previous laparoscopic adenomyomectomy scar. ( 29807141 )
2018
18
The effectiveness of different treatments for caesarean ectopic pregnancy. ( 29878597 )
2018
19
National rates, trends and determinants of inpatient surgical management of tubal ectopic pregnancy in the United States, 1998-2011. ( 29359520 )
2018
20
Cesarean Scar Ectopic Pregnancy: Current Management Strategies. ( 29850919 )
2018
21
Methotrexate-induced pancytopenia in a patient with ectopic pregnancy. ( 29593825 )
2018
22
Rates of pelvic inflammatory disease and ectopic pregnancy in Australia, 2009-2014: ecological analysis of hospital data. ( 29720385 )
2018
23
ACOG Practice Bulletin No. 191 Summary: Tubal Ectopic Pregnancy. ( 29370045 )
2018
24
Magnetic resonance imaging of common, uncommon, and rare implantation sites in ectopic pregnancy. ( 29713741 )
2018
25
Ruptured caesarean scar ectopic pregnancy: a diagnostic dilemma in a resource-limited setting. ( 29751813 )
2018
26
Association between Prior <i>Chlamydia trachomatis</i> Infection and Ectopic Pregnancy at a Tertiary Care Hospital in South Western Uganda. ( 29686708 )
2018
27
Evaluation of maternal serum ischemia modified albumin and total antioxidant status in ectopic pregnancy. ( 29284337 )
2018
28
Successful diagnosis and treatment of early splenic ectopic pregnancy: A case report. ( 29703001 )
2018
29
Temporary Simultaneous Two-Arterial Occlusions (Testo) during Laparoscopic Management for Cornual Ectopic Pregnancy. ( 29371173 )
2018
30
Clinical significance of expression of hsa-mir-1247 and hsa-mir-1269a in ectopic pregnancy due to salpingitis. ( 29805512 )
2018
31
Ectopic pregnancy in women with recurrent miscarriage. ( 29442402 )
2018
32
Outcomes in subsequent pregnancies after wedge resection for interstitial ectopic pregnancy: a retrospective cohort study. ( 29400114 )
2018
33
Optimal use of peri-operative human chorionic gonadotrophin concentrations to identify persistent ectopic pregnancy after laparoscopic salpingostomy: a retrospective cohort study. ( 29352649 )
2018
34
Laparoscopic resection of cesarean scar ectopic pregnancy after unsuccessful systemic methotrexate treatment. ( 29890356 )
2018
35
Long-term risk of hysterectomy and ectopic pregnancy among Vietnamese women using the quinacrine hydrochloride pellet system vs. intrauterine devices or tubal ligation for contraception. ( 29683010 )
2018
36
Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy. ( 29429891 )
2018
37
Updated Estimates of Ectopic Pregnancy among Commercially and Medicaid-Insured Women in the United States, 2002-2013. ( 28052169 )
2017
38
Fertility outcomes after sapingectomy or salpingotomy for tubal ectopic pregnancy, a retrospective study in China. ( 28951291 )
2017
39
A Rare Case of Gestational Choriocarcinoma Presenting as Cornual Ectopic Pregnancy. ( 29032067 )
2017
40
Risk of Ectopic Pregnancy in Women With Inflammatory BowelA Disease: A 22-Year Nationwide Cohort Study. ( 28694133 )
2017
41
Clinical predictors of failing one dose of methotrexate for ectopic pregnancy after in vitro fertilization. ( 28058611 )
2017
42
Recurrent Cesarean Scar Ectopic Pregnancy Treated with Systemic Methotrexate. ( 29333307 )
2017
43
Case of spontaneous splenic rupture caused by ectopic pregnancy in the spleen. ( 28762583 )
2017
44
Preventing Ectopic Pregnancy and its Complications - What Next? ( 28029698 )
2017
45
Ectopic Pregnancy With Tubal Rupture: An Analysis Of 80 Cases. ( 28718242 )
2017
46
Outcomes of conception subsequent to methotrexate treatment for an unruptured ectopic pregnancy. ( 28710772 )
2017
47
Risk factors for ectopic pregnancy in Germany: a retrospective study of 100,197 patients. ( 29308062 )
2017
48
Ectopic pregnancy in the liver incidentally diagnosed by imaging: A case report. ( 28672941 )
2017
49
Can the Presence of a Surrounding Endometrium Differentiate Eccentrically Located Intrauterine Pregnancy from Interstitial Ectopic Pregnancy? ( 28729096 )
2017
50
Frozen-Thawed Embryo Transfer Cycles Have a Lower Incidence of Ectopic Pregnancy Compared With Fresh Embryo Transfer Cycles. ( 29254433 )
2017
Sources

Variations for Ectopic Pregnancy

About this section
Sources

Expression for Ectopic Pregnancy

About this section
Search GEO for disease gene expression data for Ectopic Pregnancy.
Sources

GO Terms for Ectopic Pregnancy

About this section

Cellular components related to Ectopic Pregnancy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 ADAM12 CGB3 CGB7 LIF PAPPA PGF
2 extracellular region GO:0005576 9.36 ADAM12 CGA CGB3 CGB5 CGB7 LIF

Biological processes related to Ectopic Pregnancy according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 G-protein coupled receptor signaling pathway GO:0007186 9.99 CGA CGB3 CGB7 PROK1 PROKR1 PROKR2
2 positive regulation of cell proliferation GO:0008284 9.8 CGA LIF PGF PROK1 VEGFA
3 positive regulation of angiogenesis GO:0045766 9.7 ADAM12 PGF VEGFA
4 cell-cell signaling GO:0007267 9.65 CGA CGB3 CGB5 CGB7 PGF
5 circadian rhythm GO:0007623 9.61 PROK1 PROKR1 PROKR2
6 positive regulation of cell division GO:0051781 9.5 PGF PROK1 VEGFA
7 induction of positive chemotaxis GO:0050930 9.49 PGF VEGFA
8 ovulation GO:0030728 9.48 CGB3 CGB7
9 cardiac muscle fiber development GO:0048739 9.46 MYH11 VEGFA
10 positive regulation of mast cell chemotaxis GO:0060754 9.37 PGF VEGFA
11 peptide hormone processing GO:0016486 9.33 CGA CGB3 CGB5
12 regulation of signaling receptor activity GO:0010469 9.23 CGA CGB3 CGB5 CGB7 LIF PGF
13 female gamete generation GO:0007292 9.13 CGB3 CGB5 CGB7
14 signal transduction GO:0007165 10.08 CGA CGB3 CGB5 CGB7 PGF PROKR1

Molecular functions related to Ectopic Pregnancy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.5 CGA CGB3 CGB7
2 neuropeptide Y receptor activity GO:0004983 9.26 PROKR1 PROKR2
3 growth factor activity GO:0008083 9.26 LIF PGF PROK1 VEGFA
4 pancreatic polypeptide receptor activity GO:0001602 9.16 PROKR1 PROKR2
5 vascular endothelial growth factor receptor binding GO:0005172 8.62 PGF VEGFA
Sources

Sources for Ectopic Pregnancy

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....